About Taste receptor type 2 member 39
Taste receptor type 2 member 39 (TAS2R39) is a protein
from Homo sapiens identified by UniProt accession
P59534, 338 residues long.
MolForge cross-references it against 0 known binders and
19 disease associations.
Target properties
| Protein name | Taste receptor type 2 member 39 |
| UniProt accession | P59534 |
| Gene | TAS2R39 |
| Organism | Homo sapiens |
| Length | 338 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (19)
Diseases linked to this target (Open Targets).
- glioblastoma multiforme · score 0.22
- lung adenocarcinoma · score 0.18
- blood protein measurement · score 0.13
- squamous cell lung carcinoma · score 0.13
- head and neck squamous cell carcinoma · score 0.13
- neuroblastoma · score 0.11
- 46,XY complete gonadal dysgenesis · score 0.05
- Testicular regression syndrome · score 0.04
- isolated congenital hypogonadotropic hypogonadism · score 0.04
- 46,XX testicular disorder of sex development · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P59534-F1 | alphafold | PREDICTED | 81.25 | — |
Amino-acid sequence (338 residues)
MLGRCFPPDT KEKQQLRMTK LCDPAESELS PFLITLILAV LLAEYLIGII ANGFIMAIHA AEWVQNKAVS TSGRILVFLS VSRIALQSLM MLEITISSTS LSFYSEDAVY YAFKISFIFL NFCSLWFAAW LSFFYFVKIA NFSYPLFLKL RWRITGLIPW LLWLSVFISF SHSMFCINIC TVYCNNSFPI HSSNSTKKTY LSEINVVGLA FFFNLGIVTP LIMFILTATL LILSLKRHTL HMGSNATGSN DPSMEAHMGA IKAISYFLIL YIFNAVALFI YLSNMFDINS LWNNLCQIIM AAYPASHSIL LIQDNPGLRR AWKRLQLRLH LYPKEWTL
Explore Taste receptor type 2 member 39 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets